Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7828]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
Personalised breast cancer therapy and the ALLTO trial
Dr Joanne Zujewski - Head of Breast Cancer Therapeutics, NCI, USA
Personalised breast cancer therapy and the ALLTO trial ( Dr Joanne Zujewski - Head of Breast Cancer Therapeutics, NCI, USA )
16 Sep 2009
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
Why attend ECCO 15 - ESMO 34?
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin? ( Why attend ECCO 15 - ESMO 34? )
22 Jul 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key...
ECCO 15 - ESMO 34
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues ( ECCO 15 - ESMO 34 )
22 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast...
Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US
PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer ( Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US )
3 Jul 2009
Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
Zoledronic acid for treament of prostate cancer ( Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals )
25 Jun 2009
ASCO: Impact of common antidepressants on tamoxifen effectiveness
Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The...
ASCO: Impact of common antidepressants on tamoxifen effectiveness ( Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands )
18 Jun 2009
AACR 2009: Circulating tumour cells as biomarkers
Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009
AACR 2009: Molecular profiling of tumours to find potential targets and...
Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S...
AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers ( Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research )
1 May 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of...
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation